| Literature DB >> 28529502 |
Agapi I Doulgeraki1, Georgios Efthimiou2, Spiros Paramithiotis3, Katherine M Pappas2, Milton A Typas2, George-John Nychas1.
Abstract
The emergence of methicillin-resistant Staphylococcus aureus (MRSA) in food has provoked a great concern about the presence of MRSA in associated foodstuff. Although MRSA is often detected in various retailed meat products, it seems that food handlers are more strongly associated with this type of food contamination. Thus, it can be easily postulated that any food could be contaminated with this pathogen in an industrial environment or in household and cause food poisoning. To this direction, the effect of rocket (Eruca sativa) extract on MRSA growth and proteome was examined in the present study. This goal was achieved with the comparative study of the MRSA strain COL proteome, cultivated in rocket extract versus the standard Luria-Bertani growth medium. The obtained results showed that MRSA was able to grow in rocket extract. In addition, proteome analysis using 2-DE method showed that MRSA strain COL is taking advantage of the sugar-, lipid-, and vitamin-rich substrate in the liquid rocket extract, although its growth was delayed in rocket extract compared to Luria-Bertani medium. This work could initiate further research about bacterial metabolism in plant-based media and defense mechanisms against plant-derived antibacterials.Entities:
Keywords: MRSA; defense; extract; metabolism; proteome; rocket
Year: 2017 PMID: 28529502 PMCID: PMC5418331 DOI: 10.3389/fmicb.2017.00782
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Nutrient composition of Luria–Bertani (LB) and rocket extract.
| LB (g per 100 mL) | Rocket extract (g per 100 mL)∗ | |
|---|---|---|
| Total lipid | 0.0045 | 0.66 |
| Total sugar | 0.008 | 2.05 |
| Total protein | 1.12 | 2.58 |
| Vitamin C (ascorbate) | 0 | 0.015 |
| Vitamin B12 (cobalamin) | 0.0000000025 | 0 |
| Iron | 0.0000202 | 0.00146 |
Details of the 16 differentially expressed protein spots observed on the 2D-gels.
| Approximate range of Mw and pI coordinates for each spot | |||||
|---|---|---|---|---|---|
| Mw (kDa) | pI | ||||
| Spot # | Presence/absence or over-expression | min | max | min | max |
| 1 | Pr | 21.5 | 23.5 | 4.4 | 4.6 |
| 2 | O | 21.5 | 23.5 | 4.4 | 4.6 |
| 3 | Pr | 22.5 | 24.5 | 5.2 | 5.4 |
| 4 | Pr | 22.5 | 24.5 | 5.3 | 5.5 |
| 5 | Pr | 20.5 | 22.5 | 5.8 | 6.0 |
| 6 | Pr | 19.5 | 21.5 | 5.7 | 5.9 |
| 7 | Pr | 22.0 | 24.0 | 6.5 | 6.7 |
| 8 | O | 18.4 | 18.6 | 4.7 | 4.9 |
| 9 | O | 18.4 | 18.6 | 4.8 | 5.0 |
| 10 | Pr | 14.5 | 16.5 | 5.0 | 5.2 |
| 11 | Pr | 14.5 | 16.5 | 5.5 | 5.7 |
| 12 | Pr | 35.0 | 37.0 | 6.3 | 6.5 |
| 13 | Pr | 35.0 | 37.0 | 6.5 | 6.7 |
| 14 | Pr | 35.0 | 37.0 | 6.6 | 6.8 |
| 15 | Pr | 35.0 | 37.0 | 7.2 | 7.4 |
| 16 | Pr | 35.0 | 37.0 | 7.3 | 7.5 |
Details of the most distinct differentially expressed protein spots and involvement of the identified proteins in specific metabolic pathways.
| Swiss-2DPAGE | ||||||
|---|---|---|---|---|---|---|
| Spot # | ID code | ID name | Mw (Da) | pI | Homologue genes in COL and N315 strains | Pathway |
| 1 | Q7A774 | 3-hexulose-6-phosphate synthase | 23438 | 4.50 | SACOL0617 | Pentose phosphate pathway; Methane metabolism |
| 3 | P99093 | 3-oxoacyl-[acyl-carrier-protein] reductase FabG | 23228 | 5.34 | SACOL1245; SACOL1299 | Biosynthesis of unsaturated fatty acids; Fatty acid biosynthesis; Biotin metabolism |
| 4 | Q7A4J0 | Putative uncharacterized protein SA1840 | 24186 | 5.44 | SACOL0874 | Nitroreductase |
| 5 | P99077 | Peptide deformylase | 21683 | 5.87 | SACOL1100; SACOL1227 | – |
| 6 | Q7A782 | FMN-dependent NADPH-azoreductase | 19732 | 5.76 | SACOL0190 | – |
| 10 | P99068 | Nucleotide diphosphate kinase | 14586 | 5.04 | SACOL1509 | Purine and pyrimidine synthesis; Synthesis of secondary metabolites |